SA
Syntax Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $232K | Sell |
282
-25
| -8% | -$20.6K | 0.2% | 136 |
|
|
2023
Q2 | $221K | Sell |
307
-13
| -4% | -$9.34K | 0.18% | 174 |
|
|
2023
Q1 | $263K | Hold |
320
| – | – | 0.2% | 125 |
|
|
2022
Q4 | $231K | Sell |
320
-39
| -11% | -$28.1K | 0.19% | 150 |
|
|
2022
Q3 | $247K | Sell |
359
-66
| -16% | -$45.4K | 0.21% | 117 |
|
|
2022
Q2 | $251K | Buy |
425
+66
| +18% | +$39K | 0.21% | 121 |
|
|
2022
Q1 | $251K | Sell |
359
-31
| -8% | -$21.7K | 0.21% | 132 |
|
|
2021
Q4 | $246K | Buy |
+390
| New | +$246K | 0.18% | 177 |
|